stockrow
Friday 6 November 2026
Export SDGR’s income statement to Excel — free account
Schrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
29.96
1.19
+4.14%
Follow SDGR
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 3 | 5 |
+8 more TTM periods Free account |
| (19.02%) | (16.18%) | (30.12%) | (26.29%) | ||
| (9.36%) | (8.18%) | (15.03%) | (13.33%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(19.15%) | (17.19%) | (32.87%) | (29.54%) | |
Average Days of Receivables |
0.00 | 57.95 | 68.99 | 148.92 | |
Free Cash Flow per Share |
(1.56) | (1.74) | (2.00) | 0.17 | |
Free Cash Flow |
(116.77) | (130.27) | (148.35) | 12.46 | |
Capital Expenditures |
(4.20) | (3.40) | (3.35) | (1.44) | |
| Other line items | |||||
Cash ROIC |
(17.29%) | (17.42%) | (20.61%) | 1.63% | |
Accounts Receivable Turnover |
0.00 | 6.65 | 5.39 | 1.42 | |
Accounts Payable Turnover |
13.01 | 11.69 | 9.57 | 10.24 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
25.97 | 33.72 | 38.29 | 36.91 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.04 | 0.05 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
59.55% | 65.23% | 67.13% | 67.67% | |
Selling, General and Administrative Expense of Revenue |
48.60% | 50.87% | 52.85% | 53.30% | |
Share Based Compensation of Revenue |
13.28% | 14.93% | 15.89% | 16.80% | |
Operating CF/Net income |
1.90 | 2.34 | 1.40 | (0.13) | |
Depreciation/Fixed assets |
0.31 | 0.30 | 0.29 | 0.31 | |
Capex/Depreciation |
(0.72) | (0.58) | (0.57) | (0.24) | |
Revenue per Share |
3.60 | 3.47 | 3.45 | 3.48 | |
Operating CF per Share |
(1.50) | (1.70) | (1.96) | 0.19 | |
Capex per Share |
(0.06) | (0.05) | (0.05) | (0.02) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 4 Nov 2026